CPSC2014-07-14
GSK Recalls Panadol Advance Bottles Due to Failure to Meet Child-Resistant Closure Requirement; Sold Exclusively in Puerto Rico
GlaxoSmithKline (GSK), of Moon Township, Penn.
Hazard
The packaging is not child-resistant as required by the Poison Prevention Packaging Act. These products contain acetaminophen which is required by the Poison Prevention Packaging Act to be sealed with child-resistant packaging.
Remedy
Consumers should immediately place the product out of a child's sight and reach, and contact GSK for a refund.
Sold at
Drug, grocery and mass merchandise stores in Puerto Rico from November 2012 through February 2014 for about $10.
Affected count
About 10,600
Injuries reported
None reported.
Manufactured in
United States
Remedy type
Refund
Products
Panadol Advance® 100 count caplets
Consumer contact
GlaxoSmithKline (GSK) toll-free at (888) 912-8455 from 9 a.m. to 5 p.m. ET Monday through Friday, or online at www.us.gsk.com and click on "Media and news" in the upper left and, if not listed with current releases, click on "Press release archive" on the left side for more information.
Official notice
https://www.cpsc.gov/Recalls/2014/GSK-Recalls-Panadol-Advance-BottlesDon't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief